ProfileGDS4718 / 215296_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 74% 60% 56% 70% 68% 51% 54% 60% 73% 69% 66% 64% 51% 56% 53% 53% 54% 51% 57% 66% 58% 59% 61% 66% 64% 54% 67% 64% 72% 53% 55% 50% 68% 67% 58% 51% 59% 65% 56% 48% 61% 60% 57% 53% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.1975474
GSM549102patient 115, normal, homogenized [OPG study]6.1335160
GSM549104patient 119, normal, homogenized [OPG study]5.8427356
GSM549108patient 138, normal, homogenized [OPG study]6.8388470
GSM549119patient 077, normal, homogenized [OPG study]6.7244868
GSM549133patient 032, cancer, homogenized [OPG study]5.5278551
GSM549139patient 042, cancer, homogenized [OPG study]5.7537754
GSM549099patient 107, normal, homogenized [OPG study]6.1176260
GSM549109patient 139, normal, homogenized [OPG study]7.0991473
GSM549110patient 046, normal, homogenized [OPG study]6.7705469
GSM549114patient 063, normal, homogenized [OPG study]6.551266
GSM549122patient 082, normal, homogenized [OPG study]6.426164
GSM549134patient 033, cancer, homogenized [OPG study]5.5402751
GSM549136patient 036, cancer, homogenized [OPG study]5.8364356
GSM549140patient 044, cancer, homogenized [OPG study]5.6357553
GSM549111patient 047, normal, homogenized [OPG study]5.6714753
GSM549113patient 057, normal, homogenized [OPG study]5.6828754
GSM549132patient 031, cancer, homogenized [OPG study]5.5402151
GSM549137patient 038, cancer, homogenized [OPG study]5.9147957
GSM549142patient 047, cancer, homogenized [OPG study]6.599766
GSM549100patient 110, normal, homogenized [OPG study]5.9758658
GSM549107patient 135, normal, homogenized [OPG study]6.0397359
GSM549115patient 068, normal, homogenized [OPG study]6.2120361
GSM549116patient 072, normal, homogenized [OPG study]6.5778166
GSM549120patient 078, normal, homogenized [OPG study]6.3769864
GSM549131patient 030, cancer, homogenized [OPG study]5.7269654
GSM549118patient 074, normal, homogenized [OPG study]6.6733667
GSM549129patient 027, cancer, homogenized [OPG study]6.4237264
GSM549123patient 088, normal, homogenized [OPG study]7.0570772
GSM549124patient 006, cancer, homogenized [OPG study]5.6995353
GSM549126patient 015, cancer, homogenized [OPG study]5.8140555
GSM549128patient 025, cancer, homogenized [OPG study]5.5171650
GSM549103patient 117, normal, homogenized [OPG study]6.6591668
GSM549117patient 073, normal, homogenized [OPG study]6.6084167
GSM549138patient 041, cancer, homogenized [OPG study]5.9748558
GSM549141patient 045, cancer, homogenized [OPG study]5.5675251
GSM549130patient 028, cancer, homogenized [OPG study]6.0670959
GSM549101patient 111, normal, homogenized [OPG study]6.5080765
GSM549105patient 128, normal, homogenized [OPG study]5.8780456
GSM549106patient 134, normal, homogenized [OPG study]5.3728448
GSM549112patient 048, normal, homogenized [OPG study]6.1613861
GSM549125patient 011, cancer, homogenized [OPG study]6.115360
GSM549127patient 024, cancer, homogenized [OPG study]5.9820757
GSM549135patient 035, cancer, homogenized [OPG study]5.6896753